Press Releases

Date	Title	Company
23-Feb-2023	Severe Asthma Treatment Market is expected to reach US$ 36.18 Billion by 2033	MARKITWIRED
23-Feb-2023	Laboratory Balances and Scales Market is anticipated to hold a share of US$ 2.0 billion by 2033	MARKITWIRED
23-Feb-2023	Keratitis Treatment Market is expected to garner a value of US$ 1499.45 Million by 2033	MARKITWIRED
23-Feb-2023	8 out of 10 pharmaceutical companies say developing Covid tests and vaccines has impacted their development pipeline	Worldwide Business Research
23-Feb-2023	PharmiWeb.Jobs Welcomes Cambrex	Cambrex
23-Feb-2023	BioSenic optimizes statistical analysis for its ongoing ALLOB Phase IIb study for high-risk tibial fractures, requiring fewer patients and completes patient recruitment	BioSenic
23-Feb-2023	Applications for pharma jobs tumble prompting fears of a worsening talent crisis	APSCo
23-Feb-2023	Xspray Pharma Partners with EVERSANA® for the U.S. Launch and Commercialization of its Lead Product, Dasynoc (XS004) for the Treatment of Chronic Myeloid Leukemia (CML) and Acute Lymphatic Leukemia (ALL)	Xspray Pharma
23-Feb-2023	Carrier Screening Market is anticipated to exhibit a CAGR of 12.4% from 2023 to 2033	MARKITWIRED
23-Feb-2023	Hyaluronic Acid Personal Care Products Market is projected to reach a valuation of US$ 7.36 billion by 2033	MARKITWIRED
23-Feb-2023	Nasal Polyposis Treatment Market is likely to expand at a CAGR of 6.7% until 2033	MARKITWIRED
23-Feb-2023	Lung Cancer Therapeutics Market is projected to advance at a CAGR of 13.4% by 2032 \| FMI Study	MARKITWIRED
23-Feb-2023	Hyperpigmentation Treatment Market is expected to garner a market value of US$ 11.84 Billion \| FMI	MARKITWIRED
23-Feb-2023	Lab Automation Market is predicted to grow at a CAGR of 10.1% by 2033	MARKITWIRED
23-Feb-2023	Rise in the Chronic Oral Diseases is expected to propel the Growth of the Intraoral Scanners Market \| Future Market Insights	MARKITWIRED
23-Feb-2023	OSE Immunotherapeutics Updates on Anti-IL-7 Receptor Antagonist OSE-127/S95011, a Breakthrough Approach in Chronic Inflammatory Autoimmune Diseases and Hematology	OSE Immunotherapeutics
23-Feb-2023	Genmab Announces Initiation of Share Buy-Back Program	Genmab
23-Feb-2023	Genmab Publishes 2022 Annual Report	Genmab
23-Feb-2023	EVERSANA CONSULTING Named a Top Ranked Consulting Firm by Vault Across Asia Pacific	EVERSANA CONSULTING
23-Feb-2023	The dug of abuse testing market is expected to expand at a 5.19% CAGR over the forecast to 2031	MARKITWIRED